-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Leronlimab in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Leronlimab in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Leronlimab in Triple-Negative Breast Cancer (TNBC) Drug Details: Leronlimab (PRO-140)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Leronlimab in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Leronlimab in Metabolic Dysfunction-Associated Steatohepatitis (MASH) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Leronlimab in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Drug Details: Leronlimab (PRO-140)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Drug To Inhibit Prolylendopeptidase (Prep) For Chronic Obstructive Pulmonary Disease in Chronic Obstructive Pulmonary Disease (COPD)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Drug To Inhibit Prolylendopeptidase (Prep) For Chronic Obstructive Pulmonary Disease in Chronic Obstructive Pulmonary Disease (COPD)...
-
Product Insights
Influenza A Virus, H3N2 Subtype Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Influenza A Virus, H3N2 Subtype Infections - Drugs In Development, 2023’, provides an overview of the Influenza A Virus, H3N2 Subtype Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Influenza A Virus, H3N2 Subtype Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development...
-
Product Insights
Influenzavirus A Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Influenzavirus A Infections - Drugs In Development, 2023’, provides an overview of the Influenzavirus A Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Influenzavirus A Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Human Immunodeficiency Virus (HIV) Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
HIV Tests Pipeline Market Report Overview Human Immunodeficiency Virus (HIV) tests refer to the antigens, antibodies, and nucleic acid reagent tests performed for the detection of HIV type I. The HIV Tests pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated...
-
Product Insights
External Remote Patient Monitoring Devices Pipeline by Development Stages, Segments, Countries, Regulatory Path and Key Companies
External Remote Patient Monitoring Devices Pipeline Market Report Overview An External Remote Patient Monitoring Device retrieves the data from the external measurement device such as glucose meters. The device then transmits the data through a wireless system to a monitoring station or a physician’s office for further analysis and interpretation. The External Remote Patient Monitoring Devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Leronlimab in Non-Alcoholic Steatohepatitis (NASH)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Leronlimab in Non-Alcoholic Steatohepatitis (NASH) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Leronlimab in Non-Alcoholic Steatohepatitis (NASH) Drug Details: Leronlimab (PRO-140) is under...
-
Product Insights
HIV Point of Care (POC) Tests Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
HIV Point of Care (POC) Pipeline Market Report Overview Point of Care Testing (POC) is typically performed by non-laboratory personnel outside the clinical laboratory close to where the patient is receiving care. The results obtained from such tests are used for clinical decision-making. The HIV Point of Care (POC) pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cefiderocol Sulfate Tosylate in Resistant Pseudomonas aeruginosa Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cefiderocol Sulfate Tosylate in Resistant Pseudomonas aeruginosa Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cefiderocol Sulfate Tosylate in Resistant Pseudomonas aeruginosa Infections...